Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Prat

Showing results (51-60 of 268) with videos related to

Pageof 27
Sort By:
Annals of Neurology|October 8, 2009
Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosisHania Kebir, Igal Ifergan, Jorge Ivan Alvarez, et al.
Frontiers in Immunology|January 19, 2016
Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple SclerosisRui Li, Ayman Rezk, Luke M Healy, et al.
Journal of Neuroimmunology|April 25, 2018
Epstein-Barr virus-associated immune reconstitution inflammatory syndrome as possible cause of fulminant multiple sclerosis relapse after natalizumab interruptionBarbara Serafini, Stephanie Zandee, Barbara Rosicarelli, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 23, 2013
Treatment optimization in MS: Canadian MS Working Group updated recommendationsMark S Freedman, Daniel Selchen, Douglas L Arnold, et al.
Neurobiology of Disease|April 4, 2016
EphrinB1 and EphrinB2 regulate T cell chemotaxis and migration in experimental autoimmune encephalomyelitis and multiple sclerosisHongyu Luo, Bieke Broux, Xuehai Wang, et al.
Expert Review of Neurotherapeutics|June 15, 2019
Assessing the risk of multiple sclerosis disease-modifying therapiesXavier Ayrignac, Philippe-Antoine Bilodeau, Alexandre Prat, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 28, 2020
Frailty in ageing persons with multiple sclerosisXavier Ayrignac, Catherine Larochelle, Mark Keezer, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Exploration of individual beta cell function over time <i>in vivo:</i> effects of hyperglycemia and glucagon-like peptide-1 receptor (GLP1R) agonismLuis Fernando Delgadillo-Silva, Shadai Salazar, Livia Lopez Noriega, et al.
Pharmaceutics|June 10, 2020
Erratum: Puscas, I.; et al. IVIVC Assessment of Two Mouse Brain Endothelial Cell Models for Drug Screening. <i>Pharmaceutics</i> 2019, <i>11</i>, 587Ina Puscas, Florian Bernard-Patrzynski, Martin Jutras, et al.
Pharmaceutics|November 14, 2019
IVIVC Assessment of Two Mouse Brain Endothelial Cell Models for Drug ScreeningIna Puscas, Florian Bernard-Patrzynski, Martin Jutras, et al.
Pageof 27

Showing results (51-60 of 268) with videos related to

Sort By:
Pageof 27
Annals of Neurology|October 8, 2009
Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosisHania Kebir, Igal Ifergan, Jorge Ivan Alvarez, et al.
Frontiers in Immunology|January 19, 2016
Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple SclerosisRui Li, Ayman Rezk, Luke M Healy, et al.
Journal of Neuroimmunology|April 25, 2018
Epstein-Barr virus-associated immune reconstitution inflammatory syndrome as possible cause of fulminant multiple sclerosis relapse after natalizumab interruptionBarbara Serafini, Stephanie Zandee, Barbara Rosicarelli, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 23, 2013
Treatment optimization in MS: Canadian MS Working Group updated recommendationsMark S Freedman, Daniel Selchen, Douglas L Arnold, et al.
Neurobiology of Disease|April 4, 2016
EphrinB1 and EphrinB2 regulate T cell chemotaxis and migration in experimental autoimmune encephalomyelitis and multiple sclerosisHongyu Luo, Bieke Broux, Xuehai Wang, et al.
Expert Review of Neurotherapeutics|June 15, 2019
Assessing the risk of multiple sclerosis disease-modifying therapiesXavier Ayrignac, Philippe-Antoine Bilodeau, Alexandre Prat, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 28, 2020
Frailty in ageing persons with multiple sclerosisXavier Ayrignac, Catherine Larochelle, Mark Keezer, et al.
Biorxiv : the Preprint Server for Biology|April 16, 2025
Exploration of individual beta cell function over time <i>in vivo:</i> effects of hyperglycemia and glucagon-like peptide-1 receptor (GLP1R) agonismLuis Fernando Delgadillo-Silva, Shadai Salazar, Livia Lopez Noriega, et al.
Pharmaceutics|June 10, 2020
Erratum: Puscas, I.; et al. IVIVC Assessment of Two Mouse Brain Endothelial Cell Models for Drug Screening. <i>Pharmaceutics</i> 2019, <i>11</i>, 587Ina Puscas, Florian Bernard-Patrzynski, Martin Jutras, et al.
Pharmaceutics|November 14, 2019
IVIVC Assessment of Two Mouse Brain Endothelial Cell Models for Drug ScreeningIna Puscas, Florian Bernard-Patrzynski, Martin Jutras, et al.
Pageof 27